Table 3.
Tendon related reports with associated risk factors.
| Levofloxacin N = 1208 |
Ciprofloxacin N = 856 |
Moxifloxacin N = 82 |
Ofloxacin N = 91 |
Norfloxacin N = 32 |
Overall N = 2269, n (%) |
|
|---|---|---|---|---|---|---|
| Dose | ||||||
| High dose | 107 | 16 | 0 | 5 | 0 | 128 (5.64) |
| Low dose | 296 | 253 | 35 | 30 | 19 | 633 (27.90) |
| Unknown | 805 | 587 | 47 | 56 | 13 | 1508 (66.46) |
| Treatment duration ≤ 7 days | ||||||
| N: | 656 | 448 | 43 | 39 | 21 | 1207 (53.20) |
| Dose: (high/low/unknown) | (67/194/395) | (10/126/312) | (0/23/20) | (3/15/21) | (0/12/9) | (80/370/757) |
| Treatment duration > 7 days | ||||||
| N: | 381 | 248 | 23 | 35 | 9 | 696 (30.67) |
| Dose: (high/low/unknown) | (30/70/281) | (7/78/163) | (0/5/18) | (2/13/20) | (0/6/3) | (39/172/485) |
| Treatment duration unknown | ||||||
| 171 | 160 | 16 | 17 | 2 | 366 (16.13) | |
| Age ≥ 65 | ||||||
| N: | 405 | 145 | 5 | 32 | 10 | 597 (26.31) |
| Gender: (male/female/unknown) | (212/189/4) | (69/72/4) | (4/1/0) | (20/12/0) | (6/4/0) | (311/278/8) |
| Age 18–64 | ||||||
| N: | 668 | 639 | 67 | 46 | 21 | 1441 (63.50) |
| Gender: (male/female/unknown) | (225/439/4) | (269/363/7) | 25/42/0) | (27/19/0) | (6/15/0) | (552/878/11) |
| Corticosteroids treatment | ||||||
| N: | 88 | 49 | 2 | 12 | 1 | 152 (6.70) |
| Age (y.o) | ||||||
| ≥ 65/18–64 | 43/34 | 25/21 | 0/2 | 6/6 | 1/0 | 75/63 |
N number of FQs numbered once per report; n number of FQs numbered once per report, in a given category; NA not applicable; y.o years old.